NEWS

10/Mar/26

FGK Clinical Research establishes operational presence in the Netherlands to bolster European clinical trial landscape

Press Release
Weiterlesen
28/Jul/25

Insights from the EMA GCP Inspectors’ Working Group Annual Report

If you think your study has a lot going on, wait until you see what 2024 looked like on the inspection side!…
Weiterlesen
8/Jan/26

Neujahrsgespräch des Venture Capital Magazins mit Martin Krauss, Geschäftsführer FGK Clinical Research GmbH

„Für 2026 erwarten wir, dass technologische Innovationen in klinischen Studien weiter an Bedeutung gewinnen“…
Weiterlesen
28/Jul/25

COMBINE: European cross-sector initiative to streamline combined studies

In June 2025, a pilot coordinated assessment process for multinational studies that combine a medicinal product and an in vitro diagnostic medical…
Weiterlesen
29/Apr/25

Biostatistik in klinischen Studien – BioM Workshop mit Olaf Böhm

Olaf Böhm (Director Central Services bei FGK Clinical Research) hält am 29. April 2025 zum wiederholten Male den BioM-Workshop „Biostatistik in…
Weiterlesen
21/Feb/24

FGK Clinical Research GmbH Acquires Clinicology Ltd., Expanding Territorial Footprint in Europe

Press Release
Weiterlesen
13/Nov/23

Gemeinsame Pressemitteilung: Gemeinsame Mustervertragsklauseln 2.0: Beschleunigungshilfe für klinische Prüfungen am Studienstandort Deutschland

Press Release
Weiterlesen
25/May/23

Reinforcing Patient Inclusion Through Education: FGK Donates to EUPATI with FindMeCure’s TrialHub

Press Release
Weiterlesen
23/May/23

BVMA Symposium 2023 in Munich

The 31st BVMA Symposium with a focus on „Re-Thinking Clinical Research: From Patients to AI“ will take place on November 24, 2023 at the Holiday Inn…
Weiterlesen
21/Feb/23

Martin Krauss on how CTIS endangers the future of clinical studies in Europe

One year after its launch, the CTIS portal suffers from serious deficiencies, severely impairing the application procedure for clinical studies in all…
Weiterlesen